The Long Game Pays Off: How Different Patent Strategies Powered Biotech’s Biggest Exits in 2025

Early-stage biotech companies generally understand that intellectual property management, in particular, patenting their crown-jewel technology, is a critical component of sound business strategy.  But how might investment in the development of a patent portfolio pay off down the line?